# Douglas B. Johnson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/douglas-b-johnson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48,802 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 101 |
| i10-index | 303 |
| Last Known Institution | Vanderbilt University Medical Center |
| OpenAlex ID | https://openalex.org/A5025067315 |
| ORCID iD | https://orcid.org/0000-0002-6390-773X |
| Works | 737 |

## Researcher papers

Showing 12 of 13.

- [Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma](https://scholariq.org/papers/completion-dissection-or-observation-for-sentinel-node-metastasis-in-melanoma/)
- [Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events](https://scholariq.org/papers/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immune/)
- [Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab](https://scholariq.org/papers/anti-pd-1-therapy-in-patients-with-advanced-melanoma-and-preexisting-autoimmune/)
- [Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors](https://scholariq.org/papers/assessing-tumor-infiltrating-lymphocytes-in-solid-tumors-a-practical-review-for/)
- [Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research](https://scholariq.org/papers/assessing-tumor-infiltrating-lymphocytes-in-solid-tumors-a-practical-review-for-2/)
- [Assessing the Accuracy and Reliability of AI-Generated Medical Responses: An Evaluation of the Chat-GPT Model](https://scholariq.org/papers/assessing-the-accuracy-and-reliability-of-ai-generated-medical-responses-an/)
- [Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy](https://scholariq.org/papers/melanoma-specific-mhc-ii-expression-represents-a-tumour-autonomous-phenotype-and/)
- [Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade](https://scholariq.org/papers/targeted-next-generation-sequencing-identifies-markers-of-response-to-pd-1/)
- [Accuracy and Reliability of Chatbot Responses to Physician Questions](https://scholariq.org/papers/accuracy-and-reliability-of-chatbot-responses-to-physician-questions/)
- [Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study](https://scholariq.org/papers/clinical-features-and-outcomes-of-immune-checkpoint-inhibitor-associated-aki-a/)
- [High response rate to PD-1 blockade in desmoplastic melanomas](https://scholariq.org/papers/high-response-rate-to-pd-1-blockade-in-desmoplastic-melanomas/)
- [Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer](https://scholariq.org/papers/clinical-outcomes-and-toxic-effects-of-single-agent-immune-checkpoint-inhibitors/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Vanderbilt University Medical Center](https://scholariq.org/institutions/vanderbilt-university-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.